HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Joan Montaner Selected Research

Tissue Plasminogen Activator (Alteplase)

2/2015NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
10/2014Prognostic value of plasma chitotriosidase activity in acute stroke patients.
2/2014Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis.
11/2013Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.
1/2013Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
11/2012A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
10/2012IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.
5/2012Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
8/2011Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.
1/2011Ischemic stroke outcome and early infection: its deleterious effect seems to operate also among tissue plasminogen activator-treated patients.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Joan Montaner Research Topics

Disease

120Stroke (Strokes)
12/2015 - 06/2002
13Brain Ischemia (Cerebral Ischemia)
10/2015 - 12/2003
12Cerebral Hemorrhage
03/2015 - 07/2003
10Brain Injuries (Brain Injury)
08/2011 - 07/2005
8Ischemia
10/2015 - 02/2003
8Inflammation
10/2015 - 07/2006
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2014 - 07/2005
5Hemorrhage
02/2015 - 07/2010
4Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
06/2014 - 08/2010
4Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2014 - 09/2004
4Edema
01/2014 - 11/2005
4Infection
01/2014 - 01/2011
4Cardiovascular Diseases (Cardiovascular Disease)
02/2012 - 04/2007
4Transient Ischemic Attack
01/2012 - 10/2003
3Wounds and Injuries (Trauma)
01/2013 - 08/2008
3Diabetes Mellitus
01/2013 - 05/2003
2Hypertension (High Blood Pressure)
09/2015 - 02/2014
2Pneumonia (Pneumonitis)
08/2015 - 05/2015
2Hypothermia
07/2014 - 02/2014
2Brain Diseases (Brain Disorder)
04/2014 - 07/2006
2Atrial Fibrillation
11/2013 - 08/2008
2Hematoma
06/2013 - 03/2007
2Atherosclerosis
01/2012 - 12/2007
2Pathologic Constriction (Stenosis)
09/2011 - 01/2005
2Hyperglycemia
11/2004 - 05/2003
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
10/2015
1Alzheimer Disease (Alzheimer's Disease)
10/2015
1Respiratory Tract Infections (Respiratory Tract Infection)
08/2015
1Fabry Disease (Fabry's Disease)
01/2015
1Leukemia
05/2014
1Pathologic Processes
01/2014

Drug/Important Bio-Agent (IBA)

43Tissue Plasminogen Activator (Alteplase)FDA Link
02/2015 - 06/2002
19Biological Markers (Surrogate Marker)IBA
08/2015 - 11/2006
16Matrix MetalloproteinasesIBA
10/2015 - 09/2003
11glucuronyl glucosamine glycan sulfate (Vessel)IBA
09/2015 - 02/2004
10Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2015 - 02/2003
9Proteins (Proteins, Gene)IBA
07/2014 - 07/2003
7C-Reactive ProteinIBA
08/2015 - 10/2003
41-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
12/2014 - 09/2011
4Plasminogen Activator Inhibitor 1IBA
05/2014 - 06/2004
4CytokinesIBA
05/2014 - 12/2010
4Apolipoproteins E (ApoE)IBA
06/2013 - 12/2010
4fibrin fragment D (D-dimer)IBA
08/2012 - 07/2006
3erucylphosphocholineIBA
10/2015 - 12/2010
3Natriuretic PeptidesIBA
05/2015 - 12/2013
3ChemokinesIBA
05/2014 - 01/2009
3Glucose (Dextrose)FDA LinkGeneric
02/2014 - 05/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 01/2005
3Amyloid (Amyloid Fibrils)IBA
01/2012 - 07/2009
3danaproid (danaparoid)FDA Link
09/2010 - 02/2004
3Fibrinogen (Factor I)FDA Link
09/2006 - 05/2006
2Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
12/2015 - 01/2013
2Interleukin-4 (Interleukin 4)IBA
10/2015 - 05/2014
2pro-brain natriuretic peptide (1-76)IBA
05/2015 - 12/2013
2Brain Natriuretic Peptide (Natrecor)FDA Link
05/2015 - 12/2013
2Dipyridamole (Persantine)FDA LinkGeneric
01/2015 - 02/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015 - 01/2009
2Simvastatin (Zocor)FDA LinkGeneric
07/2014 - 11/2013
2OxygenIBA
02/2014 - 04/2010
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2014 - 11/2009
2platelet-derived growth factor BB (becaplermin)FDA Link
01/2014 - 05/2011
2Blood Glucose (Blood Sugar)IBA
01/2014 - 04/2006
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 01/2014
2Staphylococcal Protein A (A, Protein)IBA
11/2013 - 04/2007
25-Lipoxygenase-Activating ProteinsIBA
03/2012 - 01/2010
25'-palmitoyl cytarabine (PLAC)IBA
02/2012 - 09/2011
2Glutathione Transferase (Glutathione S-Transferase)IBA
01/2012 - 03/2011
2human AOC3 proteinIBA
01/2012 - 07/2010
2EndostatinsIBA
05/2011 - 01/2005
2Metalloproteases (Metalloproteinases)IBA
08/2010 - 01/2009
2CholesterolIBA
10/2009 - 01/2008
2ThrombinFDA Link
10/2009 - 04/2003
2Carboxypeptidase U (TAFI)IBA
09/2004 - 04/2003
1procalcitoninIBA
08/2015
1First StepIBA
05/2015
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2015
1alpha-Galactosidase (Beano)IBA
01/2015
1clopidogrel (Plavix)FDA Link
01/2015
1Neuroprotective AgentsIBA
01/2015
1HormonesIBA
12/2014
1chitotriosidaseIBA
10/2014
1Interleukin-6 (Interleukin 6)IBA
09/2014
1Buspirone (Buspar)FDA LinkGeneric
07/2014
1Meperidine (Pethidine)FDA LinkGeneric
07/2014
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014
1Interleukin-12 Subunit p40IBA
05/2014
14-(fluoromethyl)phenyl phosphate (FMPP)IBA
02/2014
1Nylons (Nylon)IBA
01/2014
1Glutamic Acid (Glutamate)FDA Link
01/2014
1salicylhydroxamic acid (SHAM)IBA
01/2014
1Cystatin AIBA
12/2013

Therapy/Procedure

9Thrombolytic Therapy
06/2010 - 07/2005
4Transplantation (Transplant Recipients)
10/2015 - 08/2012
3Endovascular Procedures
07/2014 - 01/2012
2Microbubbles
10/2008 - 02/2006
1Immunomodulation
10/2015
1Intra-Arterial Injections
10/2015
1Compression Stockings
10/2014
1Intravenous Infusions
07/2014
1Cell Transplantation
01/2014